8-K: NewLake Capital Reports Strong Q2 2025 Financials

Sentiment:

Quarterly Results


NewLake Capital Partners announced robust second quarter 2025 financial results, showcasing revenue and AFFO growth despite cannabis industry challenges.

Better than expectedRevenue increased by 3.8% year-over-year for Q2 2025, and 4.3% for the six months ended June 30, 2025.Funds From Operations (FFO) grew by 7.7% year-over-year for Q2 2025.Adjusted Funds From Operations (AFFO) increased by 4.0% year-over-year for Q2 2025.The company maintained a strong AFFO payout ratio of 79% while achieving growth in key operational metrics despite acknowledged 'ongoing challenges in the cannabis industry'.The company's balance sheet remains robust with high liquidity and very low debt.

Summary

  • NewLake Capital Partners reported second quarter 2025 revenue of $12.9 million, a 3.8% increase year-over-year.
  • Net income attributable to common stockholders for Q2 2025 totaled $7.3 million, up from $6.8 million in Q2 2024.
  • Funds From Operations (FFO) reached $11.4 million, a 7.7% year-over-year increase, and Adjusted Funds From Operations (AFFO) totaled $11.5 million, up 4.0% year-over-year.
  • For the six months ended June 30, 2025, revenue was $26.1 million, a 4.3% increase from the prior year period.
  • FFO for the six months ended June 30, 2025, was $21.6 million, and AFFO was $22.2 million.
  • The company declared a second quarter dividend of $0.43 per common share, consistent with the prior year, representing a 79% AFFO payout ratio.
  • As of June 30, 2025, cash and cash equivalents stood at $21.9 million, with total liquidity of $104.3 million.
  • Gross real estate assets were $432.2 million, with a low 1.6% debt to total gross assets and a debt service coverage ratio of approximately 95x.
  • NewLake completed $1.735 million in acquisitions during the six months ended June 30, 2025, including dispensaries in Ohio and Pennsylvania.
  • A deed-for-deed like-kind exchange was completed on June 12, 2025, involving properties in Mokena, IL, and Brookville, PA.
  • Revolutionary Clinics, a tenant, entered receivership in December 2024 and vacated its premises in July 2025; the property is actively being marketed for re-leasing.
  • AYR Wellness Inc., representing approximately 5.9% of rental revenue, entered a restructuring support agreement on July 30, 2025, and August rent payments have not been received; NewLake holds 3.5 months of security deposits for these properties.

Sentiment

Score: 7

Explanation: The company reported strong financial performance with growth in revenue, FFO, and AFFO, maintaining a healthy dividend payout and a robust balance sheet with low debt. It also shows significant outperformance against peers in key growth metrics. However, the ongoing operational challenges with two key tenants (Revolutionary Clinics and AYR Wellness) introduce notable risks to future rental income, tempering an otherwise very positive report.

Positives

  • Revenue increased by 3.8% year-over-year for Q2 2025 to $12.9 million, demonstrating continued top-line growth.
  • Funds From Operations (FFO) grew by 7.7% year-over-year to $11.4 million in Q2 2025, indicating strong operational performance.
  • Adjusted Funds From Operations (AFFO) increased by 4.0% year-over-year to $11.5 million in Q2 2025, reflecting healthy cash flow generation.
  • Maintained a consistent quarterly dividend of $0.43 per common share, with a healthy 79% AFFO payout ratio.
  • Strong balance sheet with $21.9 million in cash and cash equivalents and $104.3 million in total liquidity as of June 30, 2025.
  • Very low debt to total gross assets at 1.6% and a high debt service coverage ratio of approximately 95x, indicating robust financial stability.
  • No debt maturity until May 2027, providing long-term financial flexibility.
  • The company has a 97% rent collection rate across its triple-net leases, highlighting portfolio stability.
  • Demonstrated significant dividend growth of 79% since its IPO in Q3 2021.
  • Outperformed cannabis REIT peers and non-cannabis REIT peers in 3-year growth of cash flow per share (49% for NLCP vs. -12% for cannabis peers and 6% for non-cannabis peers).
  • Outperformed cannabis REIT peers and non-cannabis REIT peers in 3-year growth of dividend per share (98% for NLCP vs. 18% for cannabis peers and 12% for non-cannabis peers).
  • The company's valuation metrics (AFFO multiple of 6.3x and Price to Book of 0.7x) suggest it is undervalued compared to non-cannabis REIT peers (13.8x and 1.5x respectively).

Negatives

  • Net income attributable to common stockholders for the six months ended June 30, 2025, slightly decreased to $13.6 million from $13.7 million in the prior year period.
  • Revolutionary Clinics, a tenant representing a portion of rental revenue, entered receivership and subsequently vacated its property in July 2025, leading to potential re-leasing challenges and revenue disruption.
  • AYR Wellness Inc., another tenant accounting for approximately 5.9% of rental revenue, entered a restructuring support agreement, and August 2025 rent payments have not been received, posing a risk to future rental income from these properties.
  • The interest rate on the Revolving Credit Facility increased to 8.50% as of June 30, 2025, from a fixed rate of 5.65% through May 5, 2025, increasing borrowing costs.

Risks

  • Ongoing challenges in the cannabis industry could impact tenant performance and rent collection.
  • The receivership and subsequent vacation of the Revolutionary Clinics property pose a risk of vacancy and the need to find a new tenant, which could result in lost rental income and re-leasing costs.
  • The restructuring of AYR Wellness Inc. and the non-receipt of August rent payments indicate a significant risk of default and potential loss of rental revenue from properties leased to AYR, which represent 5.9% of the company's rental revenue.
  • The company's reliance on a limited number of state-licensed cannabis operators as tenants exposes it to concentration risk.
  • The legal status of cannabis at the federal level remains a risk, despite ongoing reform efforts, which could affect the industry's growth and access to traditional financial services.
  • Future changes in interest rates could increase the cost of borrowings under the variable-rate Revolving Credit Facility.

Future Outlook

The company anticipates continued growth driven by the expanding cannabis industry, with catalysts including new state-level medical and adult-use markets, and potential federal reforms such as the SAFER Banking Act, STATES Act, and DEA rescheduling of cannabis. Management expects to maintain a strong financial position and disciplined execution despite ongoing industry challenges.

Management Comments

  • "Our second quarter results demonstrate the continued stability of our business model, said Anthony Coniglio, NewLake's President and Chief Executive Officer. We generated revenue and AFFO growth while maintaining a 79% AFFO payout ratio, reflecting disciplined execution despite ongoing challenges in the cannabis industry."

Industry Context

The announcement highlights NewLake Capital Partners' continued growth within the U.S. state-licensed cannabis real estate sector, a niche market characterized by significant demand for real estate capital due to ongoing expansion and evolving legal frameworks. The company operates in a landscape where state-level legalization is progressing, with 92% of the U.S. population residing in medical markets and 52% in adult-use markets. Federal reform, including the potential rescheduling of cannabis and banking access legislation, is seen as a significant catalyst for the industry. Despite these growth drivers, the industry faces 'ongoing challenges,' as evidenced by tenant specific issues like the receivership of Revolutionary Clinics and the restructuring of AYR Wellness, underscoring the inherent risks in this nascent but rapidly developing sector.

Comparison to Industry Standards

  • NewLake Capital Partners (NLCP) has an AFFO Multiple of 6.3x, comparable to Cannabis Mortgage REIT Peers (6.3x), but significantly undervalued compared to Non-Cannabis REIT Peers (13.8x).
  • NLCP's Price to Book ratio is 0.7x, aligning with Cannabis Mortgage REIT Peers (0.7x) but substantially lower than Non-Cannabis REIT Peers (1.5x), indicating potential undervaluation.
  • NLCP's Dividend Yield of 12.3% is higher than Non-Cannabis REIT Peers (5.3%) but lower than Cannabis Mortgage REIT Peers (17.2%) and IIPR (14.5%).
  • NLCP's Debt to Equity ratio of 1.9% is remarkably low compared to IIPR (15.5%), Non-Cannabis REIT Peers (80.2%), and Cannabis Mortgage REIT Peers (41.7%), showcasing superior financial leverage management.
  • NLCP demonstrated exceptional 3-year growth in Cash Flow per Share at 49%, significantly outperforming Cannabis REIT Peers (-12%) and Non-Cannabis REIT Peers (6%).
  • NLCP's 3-year growth in Dividend per Share was 98%, vastly exceeding Cannabis REIT Peers (18%) and Non-Cannabis REIT Peers (12%).
  • NLCP's Q2 Payout Ratio of 79% is within its target 80-90% range and is more conservative than Non-Cannabis REIT Peers (90%), while being slightly higher than Cannabis REIT Peers (71%).

Stakeholder Impact

  • Shareholders: Benefit from consistent dividends ($0.43 per share) and strong AFFO payout ratio (79%), indicating reliable returns. The company's undervaluation compared to non-cannabis REITs suggests potential for capital appreciation.
  • Tenants: Revolutionary Clinics' receivership and AYR Wellness's restructuring highlight operational challenges within the cannabis industry, impacting these specific tenants' ability to meet obligations.
  • Creditors: The company's low debt to total gross assets (1.6%) and high debt service coverage ratio (~95x) indicate strong financial health and ability to meet debt obligations, providing security to creditors.

Next Steps

  • Actively market the former Revolutionary Clinics property for re-leasing following the tenant's vacation in July 2025.
  • Enforce all rights under lease agreements with AYR Wellness Inc. following their restructuring support agreement and non-receipt of August rent payments.
  • Host a conference call and webcast on August 7, 2025, to discuss Q2 2025 financial results.

Key Dates

DateDescription
2019Company founded.
2021Company IPO.
2024-06Revolutionary Clinics began paying approximately 50% of rent due.
2024-12-13Revolutionary Clinics entered into receivership.
2025-02-19Acquisition of Cresco Labs Ohio Dispensary completed.
2025-04Company retained a commercial real estate broker to market the Revolutionary Clinics property.
2025-04-25Acquisition of Cresco Labs Ohio Dispensary completed.
2025-05-06Revolving Credit Facility interest rate became variable.
2025-06-12Acquisition of Curaleaf Pennsylvania Dispensary completed through a like-kind exchange; deed-for-deed like-kind exchange with a tenant completed.
2025-06-16Board of Directors declared a second quarter 2025 cash dividend of $0.43 per share.
2025-06-30End of the second quarter 2025; record date for Q2 2025 dividend.
2025-07Revolutionary Clinics tenant vacated the premises.
2025-07-15Second quarter 2025 dividend paid.
2025-07-30AYR Wellness Inc. announced entry into a restructuring support agreement with senior noteholders.
2025-08-06Date of 8-K report; press release issued announcing Q2 2025 financial results; August rent payments from AYR Wellness not received as of this date.
2025-08-07Conference call and webcast scheduled to discuss Q2 2025 financial results; investor presentation dated.
2025-08-21Dial-in replay of the conference call available until this date.
2025-12Expected new medical cannabis licenses in Texas.
2027-05No debt maturity until this month.

Recommendation

buy

NewLake Capital Partners demonstrates strong financial health with consistent revenue, FFO, and AFFO growth, a robust balance sheet, and a healthy dividend payout. The company's low debt and high liquidity provide significant financial flexibility. While there are notable tenant-specific challenges (Revolutionary Clinics and AYR Wellness), the company holds security deposits and is actively managing these situations. Furthermore, the investor presentation highlights that NLCP is undervalued compared to non-cannabis REIT peers based on AFFO multiple and price-to-book, and has significantly outperformed peers in cash flow and dividend growth. The long-term growth catalysts for the cannabis industry, coupled with NewLake's disciplined execution and strong financial position, make it an attractive investment despite the inherent risks of the sector.

Keywords

Cannabis Real Estate, REIT, NewLake Capital Partners, NLCP, Cannabis Industry, Real Estate Investment Trust, Financial Results, FFO, AFFO, Dividend, Triple-Net Lease, Cannabis Operators, SEC Filing, 8-K

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.